Haibo Xu
Keine laufenden Positionen mehr
Profil
Haibo Xu worked as the Director of Risk Control at Bank of China (Yantai Branch) from 1993 to 2004.
He then worked as the General Manager at Shandong Province Licheng Investment Co. Ltd.
from 2004 to 2006.
In 2009, he was the Vice President at Jiangbo Pharmaceuticals, Inc. and later became the Deputy General Manager at Laiyang Jiangbo Pharmaceuticals Co., Ltd.
Mr. Xu received his undergraduate degree from Shanghai University of Finance & Economics in 1993.
Ehemalige bekannte Positionen von Haibo Xu
| Unternehmen | Position | Ende |
|---|---|---|
| Shandong Province Licheng Investment Co. Ltd. | Corporate Officer/Principal | 01.07.2006 |
| Bank of China (Yantai Branch) | Corporate Officer/Principal | 01.07.2004 |
Laiyang Jiangbo Pharmaceuticals Co., Ltd.
 Laiyang Jiangbo Pharmaceuticals Co., Ltd. Pharmaceuticals: OtherHealth Technology Laiyang Jiangbo Pharmaceuticals Co. Ltd. engages in the research, development, production, marketing, and sale of chemical drugs and traditional Chinese medicines in the People's Republic of China. Its products include itopride hydrochloride granules, and clarithromycin sustained-release, ciprofloxacin hydrochloride, baobaole chewable tablets & paracetamol tablets. The company offers products in the form of tablets, capsules, and granules for Western and Chinese herbal-based medical drugs. It sells its products through distribution sales network. The company was founded in 2003 and is headquartered in Yantai, China. | Corporate Officer/Principal | - |
Jiangbo Pharmaceuticals, Inc.
 Jiangbo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China. | Geschäftsführer | 23.10.2009 |
Ausbildung von Haibo Xu
| Shanghai University of Finance & Economics | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Jiangbo Pharmaceuticals, Inc.
Jiangbo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China. | Health Technology |
Laiyang Jiangbo Pharmaceuticals Co., Ltd.
Laiyang Jiangbo Pharmaceuticals Co., Ltd. Pharmaceuticals: OtherHealth Technology Laiyang Jiangbo Pharmaceuticals Co. Ltd. engages in the research, development, production, marketing, and sale of chemical drugs and traditional Chinese medicines in the People's Republic of China. Its products include itopride hydrochloride granules, and clarithromycin sustained-release, ciprofloxacin hydrochloride, baobaole chewable tablets & paracetamol tablets. The company offers products in the form of tablets, capsules, and granules for Western and Chinese herbal-based medical drugs. It sells its products through distribution sales network. The company was founded in 2003 and is headquartered in Yantai, China. | Health Technology |
| Shandong Province Licheng Investment Co. Ltd. | |
| Bank of China (Yantai Branch) |